Publication | Closed Access

A Phase I Study of Vaccination with Autologous, Irradiated Melanoma Cells Engineered to Secrete Human Granulocyte-Macrophage Colony Stimulating Factor. Dana-Farber Cancer Institute, Boston, Massachusetts

VaccinationRadiation OncologyTumor ImmunologyCancer ImmunosurveillanceGranulocyteImmunologyTherapeutic VaccineImmune SystemImmunotherapyMedicineCell BiologyDana-farber Cancer Institute